Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Major Surgical or Invasive Procedure:
N/A

attach
 
Pertinent Results:
___ 09:50PM BLOOD WBC-9.9 RBC-4.32* Hgb-13.3* Hct-38.6* 
MCV-89 MCH-30.8 MCHC-34.5 RDW-11.5 RDWSD-37.1 Plt ___
___ 07:05AM BLOOD WBC-8.2 RBC-4.20* Hgb-12.9* Hct-38.8* 
MCV-92 MCH-30.7 MCHC-33.2 RDW-11.6 RDWSD-39.1 Plt ___
___ 09:50PM BLOOD Glucose-103* UreaN-15 Creat-0.9 Na-138 
K-4.2 Cl-101 HCO3-24 AnGap-13
___ 07:05AM BLOOD Glucose-88 UreaN-10 Creat-0.7 Na-142 
K-4.5 Cl-103 HCO3-27 AnGap-12
___ 09:50PM BLOOD Calcium-9.7 Phos-4.1 Mg-2.2
___ 07:05AM BLOOD Mg-2.0
___ 09:50PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG 
Tricycl-NEG
___ 08:55AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG 
Tricycl-NEG
___ 09:30PM URINE bnzodzp-NEG barbitr-NEG opiates-NEG 
cocaine-NEG amphetm-NEG oxycodn-NEG mthdone-NEG
 
Brief Hospital Course:
Presented after intentional overdose of duloxetine.

# Duloxetine toxicity: The patient presented after ingestion of 
approximately 10 tablets of duloxetine 60 mg. No evidence of 
co-ingestion. The patient is now more than 48 hours after 
ingestion, with a duloxetine half life of approximately 12 
hours. The patient has no evidence on exam of serotonin 
syndrome. Patient appropriate for transfer to inpatient 
psychiatric hospitalization. Holding duloxetine

# Depression with suicide attempt: Patient with history of MDD 
with SI and prior psychiatric hospitalization but no prior 
suicide attempt. Seen by psychiatry, transferring to inpatient 
psychiatry unit for ongoing care.

# MTF transgender: Continued estradiol. Resumed spironolactone 
now that electrolytes stable

# NAFLD: Followed in ___ clinic. No evidence of fibrosis. 
Outpatient hepatology follow up

# Anemia: Mild, likely to dilution after IVF administration. No 
evidence of overt bleeding. CBC remained stable.

The patient was seen and examined on the day of discharge. The 
total time spent in preparation of discharge, counseling, and 
coordination was greater than 30 minutes.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Spironolactone 100 mg PO BID 
2. Estradiol 8 mg PO DAILY 
3. DULoxetine ___ 60 mg PO DAILY 

 
Discharge Medications:
1.  Ondansetron ODT 4 mg PO Q8H:PRN Nausea/Vomiting - First Line 
 
2.  QUEtiapine Fumarate 25 mg PO QHS:PRN insomnia  
3.  Estradiol 8 mg PO DAILY  
4.  Spironolactone 100 mg PO BID  
5. HELD- DULoxetine ___ 60 mg PO DAILY  This medication was held. 
Do not restart DULoxetine ___ ___ mental health provider 
tells you to

 
Discharge Disposition:
Extended Care
 
Discharge Diagnosis:
Suicide attempt
Toxic ingestion

 
Discharge Condition:
Mental Status: Clear and coherent.

 
Discharge Instructions:
Ms. ___,

You were seen at ___ after ingesting a large quantity of 
duloxetine. We helped you recover from this and are transferring 
you for ongoing psychiatric treatment.
 
Followup Instructions:
___